Publication: Type I and type II crustins from Penaeus monodon, genetic variation and antimicrobial activity of the most abundant crustinPm4
| dc.contributor.author | Donpudsa S. | |
| dc.contributor.author | Visetnan S. | |
| dc.contributor.author | Supungul P. | |
| dc.contributor.author | Tang S. | |
| dc.contributor.author | Tassanakajon A. | |
| dc.contributor.author | Rimphanitchayakit V. | |
| dc.date.accessioned | 2021-04-05T03:32:34Z | |
| dc.date.available | 2021-04-05T03:32:34Z | |
| dc.date.issued | 2014 | |
| dc.date.issuedBE | 2557 | |
| dc.description.abstract | An antimicrobial protein, crustin, is involved in the innate immunity of crustacean by defending the host directly against the microbial pathogens. By data mining the Penaeus monodon EST database, two type I crustins, carcinin. Pm1 and 2, and ten type II crustins, crustin. Pm1-10, were identified. The abundant crustins were crustin. Pm1, 4 and 7, each with variation in the length of Gly-rich repeat among its members. A few crustin. Pm1, 4 and 7 with deletion in the Cys-rich region were also observed. Furthermore, the crustin. Pm4 with the longest N-terminal Gly-rich region was characterized. The crustinPm4 allelic genes were expressed mainly from the hemocytes. Its expression was up-regulated readily by WSSV infection and gradually decreased to normal level afterwards. The recombinant crustin. Pm4-1 (rcrustin. Pm4-1) isoform was produced using the Escherichia coli expression system and tested for its antimicrobial activity. The rcrustin. Pm4-1 was able to inhibit the growth of a Gram-positive bacterium, Bacillus megaterium but not Bacillus subtilis, Micrococcus luteus and Staphylococcus aureus. It also inhibited the growth of two Gram-negative bacteria, E. coli 363 and Vibrio harveyi 639 at lower potency. The rcrustin. Pm4-1 affected the WSSV infection because the expression of an intermediate early gene ie1 in WSSV-infected hemocyte cell culture was reduced. It was shown further that the rcrustin. Pm4-1 could delay by about one and a half days the manifestation of disease by WSSV. © 2014 Elsevier Ltd. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Developmental and Comparative Immunology. Vol 47, No.1 (2014), p.95-103 | |
| dc.identifier.doi | 10.1016/j.dci.2014.06.015 | |
| dc.identifier.issn | 0145305X | |
| dc.identifier.other | 2-s2.0-84904880634 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/6429 | |
| dc.rights.holder | มหาวิทยาลัยศรีนครินทรวิโรฒ | |
| dc.subject.other | Humoral antibody | |
| dc.subject.other | Kanamycin | |
| dc.subject.other | Recombinant crustinPm4 1 protein | |
| dc.subject.other | Recombinant protein | |
| dc.subject.other | Thioredoxin | |
| dc.subject.other | Type 1 crustin | |
| dc.subject.other | Type 2 crustin | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Antimicrobial cationic peptide | |
| dc.subject.other | Arthropod protein | |
| dc.subject.other | Amino terminal sequence | |
| dc.subject.other | Animal cell | |
| dc.subject.other | Animal experiment | |
| dc.subject.other | Animal tissue | |
| dc.subject.other | Antimicrobial activity | |
| dc.subject.other | Antiviral activity | |
| dc.subject.other | Article | |
| dc.subject.other | Bacillus megaterium | |
| dc.subject.other | Bacillus subtilis | |
| dc.subject.other | Bacterial growth | |
| dc.subject.other | Blood cell | |
| dc.subject.other | Controlled study | |
| dc.subject.other | DNA virus infection | |
| dc.subject.other | Drug effect | |
| dc.subject.other | Escherichia coli | |
| dc.subject.other | Gene expression regulation | |
| dc.subject.other | Genetic variability | |
| dc.subject.other | Growth inhibition | |
| dc.subject.other | LD 50 | |
| dc.subject.other | Micrococcus luteus | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Nucleotide sequence | |
| dc.subject.other | Penaeus monodon | |
| dc.subject.other | Priority journal | |
| dc.subject.other | Protein expression | |
| dc.subject.other | Sequence analysis | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Upregulation | |
| dc.subject.other | Vibrio harveyi | |
| dc.subject.other | White spot syndrome virus | |
| dc.subject.other | Amino acid sequence | |
| dc.subject.other | Animal | |
| dc.subject.other | Cell culture | |
| dc.subject.other | Chemistry | |
| dc.subject.other | Genetic variability | |
| dc.subject.other | Genetics | |
| dc.subject.other | Immunology | |
| dc.subject.other | Microbiology | |
| dc.subject.other | Molecular genetics | |
| dc.subject.other | Penaeidae | |
| dc.subject.other | Sequence alignment | |
| dc.subject.other | Virology | |
| dc.subject.other | Amino Acid Sequence | |
| dc.subject.other | Animals | |
| dc.subject.other | Antimicrobial Cationic Peptides | |
| dc.subject.other | Arthropod Proteins | |
| dc.subject.other | Cells, Cultured | |
| dc.subject.other | Genetic Variation | |
| dc.subject.other | Hemocytes | |
| dc.subject.other | Molecular Sequence Data | |
| dc.subject.other | Penaeidae | |
| dc.subject.other | Sequence Alignment | |
| dc.title | Type I and type II crustins from Penaeus monodon, genetic variation and antimicrobial activity of the most abundant crustinPm4 | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904880634&doi=10.1016%2fj.dci.2014.06.015&partnerID=40&md5=c7058ef3605abcd19f09aefb0032cf6d |
